For the quarter ending 2026-03-31, CAH had $1,160M increase in cash & cash equivalents over the period. $1,677M in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net earnings/(loss) | 380 | 471 | 454 | 243 |
| Depreciation and amortization | 248 | 234 | 233 | 209 |
| Gain (loss) on sale of investments | - | - | 5 | - |
| Impairments and loss on sale of other investments | -15 | -5 | - | -1 |
| Impairments and (gain)/loss on disposal of assets, net | -185 | 14 | -2 | -33 |
| Share-based compensation | 129 | 87 | 93 | 153 |
| Provision for/(benefit from) deferred income taxes | - | - | - | 243 |
| Provision for bad debts | 20 | 14 | 13 | 12 |
| Increase in trade receivables | 17 | -341 | 539 | 466 |
| Increase in inventories | -2,094 | 2,543 | 736 | 607 |
| Increase in accounts payable | -1,163 | 2,029 | 2,147 | 1,778 |
| Repurchases of liability-classified units | 5 | 22 | - | - |
| Other accrued liabilities and operating items, net | 63 | -89 | 699 | 72 |
| Net cash provided by operating activities | 1,823 | 686 | 973 | 1,527 |
| Acquisition of subsidiaries, net of cash acquired | 42 | 1,884 | 41 | 1,395 |
| Additions to property and equipment | 146 | 131 | 108 | 232 |
| Proceeds from net investment hedge terminations | - | - | - | 0 |
| Proceeds from disposal of property and equipment | 3 | 28 | - | - |
| Purchase of short-term time deposits | - | - | - | 0 |
| Proceeds from investments | 27 | - | - | - |
| Proceeds from short-term investment in time deposit | 0 | 0 | - | 0 |
| Increase (decrease) in other investing items, net | -20 | 4 | 7 | 2 |
| Net cash used in investing activities | -181 | -1,980 | -142 | -1,631 |
| Proceeds from debt, net of issuance costs | - | - | 989 | 3,669 |
| Proceeds from long-term obligations, net of issuance costs | 1,141 | -150 | - | - |
| Reduction of long-term obligations | 113 | 12 | 512 | 11 |
| Payments to noncontrolling interests | 4 | 1 | 3 | 12 |
| Net tax withholding from share-based compensation | 2 | -1 | -80 | -1 |
| Dividends on common shares | 120 | 122 | 129 | 120 |
| Purchase of treasury shares, net | 250 | 383 | 375 | 0 |
| Net cash provided by/(used in) financing activities | -483 | -519 | -110 | 656 |
| Effect of exchange rate on cash, cash equivalent, restricted cash, and restricted cash equivalent, continuing operation | 1 | -3 | -2 | -4 |
| Net increase/(decrease) in cash and equivalents | 1,160 | -1,816 | 719 | 548 |
| Cash and equivalents at beginning of period | 2,777 | 4,593 | 3,874 | 3,326 |
| Cash and equivalents at end of period | 3,937 | 2,777 | 4,593 | 3,874 |
CARDINAL HEALTH INC (CAH)
CARDINAL HEALTH INC (CAH)